ZERONDA TYLER (Interim CFO) reported 1 transaction at VYNE THERAPEUTICS INC.
Review the transaction codes below to understand the nature of each event.
Filed: 10/2/2025ACC: 0001867033-25-000003
Officer· Interim CFO
Since Jun 2021
-3.42K
Net shares
Net seller
$1.1K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
3.42K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−3.42K
Price / share
$0.34
Trade value
$1.15K
% of position
3.0%
9/30/2025
115.07K→111.65K
Total
Net shares
−3.42K
Net value
-$1.15K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/30/2025 | F · Tax Withholding | −3.42K | $0.34 | $1.15K | 3.0% | 115.07K | 111.65K |
| Total | −3.42K | -$1.15K | ||||||
Derivative Transactions0
No derivative transactions reported